Nevada § 630.306 - Inability to practice medicine; deceptive conduct; violation of regulation governing practice of medicine or adopted by State Board of Pharmacy; unlawful distribution of controlled substance; injection of silicone; practice beyond scope of license; practicing experimental medicine without consent of patient or patient’s family; lack of skill or diligence; alcohol or other substance use disorder; filing of false report; failure to report certain changes of information or disciplinary or criminal action in another jurisdiction; failure to be found competent after examination; certain operation of a medical facility; prohibited administration of anesthesia or sedation; engaging in unsafe or unprofessional conduct; knowingly or willfully procuring or administering certain controlled substances or dangerous drugs; failure to supervise medical assistant adequately; allowing person not enrolled in accredited medical school to perform certain activities; failure to obtain required training regarding controlled substances; unauthorized injection of dermal or soft tissue fillers or botulinum toxin; failure to comply with requirements related to testing for sexually transmitted diseases; violations related to pelvic examinations

action or denying licensure: (a) Inability to practice medicine with reasonable skill and safety because of illness,

a mental or physical condition or the use of alcohol, drugs, narcotics or any other

substance. (b) Engaging in any conduct: (1) Which is intended to deceive; (2) Which the Board has determined is a violation of the standards of practice established

by regulation of the Board; or (3) Which is in violation of a provision of chapter 639 of NRS , or a regulation adopted by the State Board of Pharmacy pursuant thereto, that is

applicable to a licensee who is a practitioner, as defined in NRS 639.0125 . (c) Administering, dispensing or prescribing any controlled substance, or any dangerous

drug as defined in chapter 454 of NRS , to or for himself or herself or to others except as authorized by law. (d) Performing, assisting or advising the injection of any substance containing liquid

silicone into the human body, except for the use of silicone oil to repair a retinal

detachment. (e) Practicing or offering to practice beyond the scope permitted by law or performing

services which the licensee knows or has reason to know that he or she is not competent

to perform or which are beyond the scope of his or her training. (f) Performing, without first obtaining the informed consent of the patient or the

patient's family, any procedure or prescribing any therapy which by the current standards

of the practice of medicine is experimental. (g) Continual failure to exercise the skill or diligence or use the methods ordinarily

exercised under the same circumstances by physicians in good standing practicing in

the same specialty or field. (h) Having an alcohol or other substance use disorder. (i) Making or filing a report which the licensee or applicant knows to be false or

failing to file a record or report as required by law or regulation. (j) Failing to comply with the requirements of NRS 630.254 . (k) Failure by a licensee or applicant to report in writing, within 30 days, any disciplinary

action taken against the licensee or applicant by another state, the Federal Government

or a foreign country, including, without limitation, the revocation, suspension or

surrender of a license to practice medicine in another jurisdiction. The provisions of this paragraph do not apply to any disciplinary action taken by

the Board or taken because of any disciplinary action taken by the Board. (l) Failure by a licensee or applicant to report in writing, within 30 days, any criminal

action taken or conviction obtained against the licensee or applicant, other than

a minor traffic violation, in this State or any other state or by the Federal Government,

a branch of the Armed Forces of the United States or any local or federal jurisdiction

of a foreign country. (m) Failure to be found competent to practice medicine as a result of an examination

to determine medical competency pursuant to NRS 630.318 . (n) Operation of a medical facility at any time during which: (1) The license of the facility is suspended or revoked; or (2) An act or omission occurs which results in the suspension or revocation of the

license pursuant to NRS 449.160 . This paragraph applies to an owner or other principal responsible for the operation

of the facility. (o) Failure to comply with the requirements of NRS 630.373 . (p) Engaging in any act that is unsafe or unprofessional conduct in accordance with

regulations adopted by the Board. (q) Knowingly or willfully procuring or administering a controlled substance or a

dangerous drug as defined in chapter 454 of NRS that is not approved by the United States Food and Drug Administration, unless the

unapproved controlled substance or dangerous drug: (1) Was procured through a retail pharmacy licensed pursuant to chapter 639 of NRS ; (2) Was procured through a Canadian pharmacy which is licensed pursuant to chapter 639 of NRS and which has been recommended by the State Board of Pharmacy pursuant to subsection

4 of NRS 639.2328 ; (3) Is cannabis being used for medical purposes in accordance with chapter 678C of NRS ; or (4) Is an individualized investigational treatment or investigational drug or biological

product prescribed to a patient pursuant to NRS 630.3735 or 633.6945 . (r) Failure to supervise adequately a medical assistant pursuant to the regulations

of the Board. (s) Failure to comply with the provisions of NRS 630.3745 . (t) Failure to obtain any training required by the Board pursuant to NRS 630.2535 . (u) Failure to comply with the provisions of NRS 454.217 or 629.086 . (v) Failure to comply with the provisions of NRS 441A.315 or any regulations adopted pursuant thereto. (w) Performing or supervising the performance of a pelvic examination in violation

of NRS 629.085 . 2. As used in this section: (a) “ Individualized investigational treatment ” has the meaning ascribed to it in NRS 454.690 . (b) “ Investigational drug or biological product ” has the meaning ascribed to it in NRS 454.351 .